Knight Therapeutics Inc. named one of Quebec's Top Growing Companies in The Globe and Mail's inaugural ranking, with 53% three-year revenue growth
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® for Cutaneous T-Cell Lymphoma Patients Across Latin America
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo®
Knight Therapeutics Inc. places No. 345 on The Globe and Mail's eighth annual ranking of Canada's Top Growing Companies
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.